Mickle Travis C 4
4 · KEMPHARM, INC · Filed May 25, 2022
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Mickle Travis C
DirectorPresident & CEO10% Owner
Transactions
- Purchase
Common Stock
2022-05-25$4.39/sh+10,000$43,900→ 11,034 total(indirect: By LLC) - Purchase
Common Stock
2022-05-25$4.36/sh+2,000$8,711→ 38,521 total - Purchase
Common Stock
2022-05-25$4.38/sh+1,000$4,385→ 39,521 total
Holdings
- 15,242(indirect: By Trust)
Common Stock
- 9,824(indirect: By Trust)
Common Stock
- 96,153(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The Reporting Person is the sole manager member of Mickle Investments, LLC.
- [F2]The Reporting Person is the sole manager member of Mickle Holdings, LLC.